Behcet disease is a heterogeneous, multisystem inflammatory disorder; vascular involvement has been considered to result from systemic vasculitis, which most frequently affects veins and occurs in 5% to 10% of these patients. However, superior vena cava (SVC) involvement is rare; it accounts for only 6% of the cases. The aim of this article is to a report on a case of SVC recanalization through the use of fibrinolysis and self-expanding stents as treatment of life-threatening SVC syndrome in a young male patient with Behcet disease.
Endovascular treatment for superior vena cava obstruction in Behçet disease / P. Castelli, R. Caronno, G. Piffaretti, M. Tozzi, C. Lomazzi, D. Laganà, G. Carrafiello, S. Cuffari. - In: JOURNAL OF VASCULAR SURGERY. - ISSN 0741-5214. - 41:3(2005), pp. 548-551. ((Intervento presentato al 14. convegno World Congress of the Union-Internationale-de-Phlebologie tenutosi a Roma nel 2001 [10.1016/j.jvs.2004.12.034].
Endovascular treatment for superior vena cava obstruction in Behçet disease
G. CarrafielloPenultimo
;
2005
Abstract
Behcet disease is a heterogeneous, multisystem inflammatory disorder; vascular involvement has been considered to result from systemic vasculitis, which most frequently affects veins and occurs in 5% to 10% of these patients. However, superior vena cava (SVC) involvement is rare; it accounts for only 6% of the cases. The aim of this article is to a report on a case of SVC recanalization through the use of fibrinolysis and self-expanding stents as treatment of life-threatening SVC syndrome in a young male patient with Behcet disease.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0741521404017082-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
110.38 kB
Formato
Adobe PDF
|
110.38 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
